System Transmission

Top Signal

100#1 JOB

Activity

2188Ripe

+959 today

System

Live2m

Terminal Asset View

stockNASDAQ

ADCT

$4.13-5.06%

ADC Therapeutics SA Common Shares

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

25Overripe

Live Analysis Active

Company Mission

ADC Therapeutics creates cancer treatments using special antibodies that deliver toxic drugs directly to cancer cells. Doctors use these drugs to treat patients with certain types of blood cancers. The company makes money by selling these approved drugs and partnering with larger pharmaceutical companies to develop new treatments.

ADC

Industry Context

Biotechnology companies develop medical treatments using advanced science. This industry is highly volatile because stock prices react strongly to news about drug trials, regulatory approvals, and partnership announcements. Companies in this space often trade based on expectations about future drug success rather than current profits.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

77Matrix

Market Momentum

44.1— Holding Steady

Trend Strength

50— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.8x— Normal Volume

Today's Change

-5.06%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ADCT across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 06:05 PM UTC

As-of 03-14-2026 17:50 UTC

Develops cancer drugs that target specific tumor cells and makes money by selling these treatments to hospitals and clinics.

Price dropped nearly 11% from yesterday's close, suggesting strong selling pressure as investors reacted to recent developments.

Biotech sector volatility remains elevated as clinical trial results drive sentiment, with this stock showing heightened sensitivity to news flow,.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...